December 2nd 2024
If granted, guselkumab will be approved to treat children ages 6 and younger with severe plaque psoriasis and children ages 5 and younger with juvenile psoriatic arthritis.
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis
View More
Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?
View More
Acupuncture combats chronic skin diseases
September 1st 2006Piscataway, N.J. - Modern medical acupuncture can help patients, particularly those with chronic skin diseases, improve their overall health and avoid risks associated with systemic treatments, says an expert who has experience with acupuncture both personally and professionally.
Innate peptide antibiotics defend against microbial invasion, skin disease
September 1st 2006Philadelphia - The human body is constantly under attack from bacteria and viruses living in our environment. When we present with clinical infections, it is the direct result of our immune system's incapability of successfully protecting us from these microbes. To achieve a better understanding of skin infections, one must try to better understand the human body's defense system, as well as the microbial virulence system.
Fas signaling implicated in development of psoriasis
September 1st 2006Fas/Fas Ligand signaling, conventionally thought to be pro-apoptotic, can also send an activating signal that is an essential step in the development of psoriasis, according to results of a recent preclinical study by Amos Gilhar, M.D., of the Technion-Israel Institute of Technology, and associates.
Total body photography not standard of care
September 1st 2006Eckley M. Keach's article in the June 2006 issue of Dermatology Times ("Successful malpractice defense lies in body of evidence") provides tips for dermatologists to reduce the risk of malpractice liability from treating high-risk melanoma patients.